middle.news
Arovella Therapeutics Refreshes Board and CEO Amid Strategic Review
10:32am on Monday 4th of May, 2026 AEST
•
Biotechnology
Read Story
Arovella Therapeutics Refreshes Board and CEO Amid Strategic Review
10:32am on Monday 4th of May, 2026 AEST
Key Points
CEO Dr Michael Baker resigns with three months' notice
Three directors resign immediately following shareholder requisition
New board of three members installed with David Williams as chairman
Company initiates comprehensive review of technology and growth strategy
Read Story
middle.
Tap to Read
Tap the card to read the full analysis
about
Arovella Therapeutics (ASX:ALA)
OPEN ARTICLE